Variant report

Variant	esv1804134
Chromosome Location	chr7:139528662-139539855
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:139529332-139529539	HepG2	liver:	n/a	n/a
2	ATF1	chr7:139528842-139529018	K562	blood:	n/a	n/a
3	ATF2	chr7:139529350-139529976	GM12878	blood:	n/a	n/a
4	BATF	chr7:139529459-139529881	GM12878	blood:	n/a	n/a
5	BATF	chr7:139528827-139529129	GM12878	blood:	n/a	chr7:139528966-139528977
6	BHLHE40	chr7:139528886-139529147	GM12878	blood:	n/a	n/a
7	BHLHE40	chr7:139529261-139529262	K562	blood:	n/a	n/a
8	CEBPB	chr7:139530127-139530415	IMR90	lung:	n/a	n/a
9	CHD1	chr7:139529680-139530168	GM12878	blood:	n/a	n/a
10	CHD2	chr7:139529002-139529013	GM12878	blood:	n/a	n/a
11	CTCF	chr7:139536813-139536922	Medullo	brain:	n/a	n/a
12	CTCF	chr7:139529080-139529230	HepG2	liver:	n/a	n/a
13	CTCF	chr7:139528980-139529130	GM12875	blood:	n/a	n/a
14	CTCF	chr7:139529060-139529210	A549	lung:	n/a	n/a
15	CTCF	chr7:139528980-139529130	GM12873	blood:	n/a	n/a
16	CTCF	chr7:139528980-139529130	GM12864	blood:	n/a	n/a
17	CTCF	chr7:139529100-139529250	GM12873	blood:	n/a	n/a
18	CTCF	chr7:139529020-139529170	GM12873	blood:	n/a	n/a
19	E2F6	chr7:139528968-139529219	K562	blood:	n/a	n/a
20	EBF1	chr7:139529343-139529348	GM12878	blood:	n/a	n/a
21	EBF1	chr7:139529633-139529748	GM12878	blood:	n/a	n/a
22	ELF1	chr7:139530849-139531284	GM12878	blood:	n/a	chr7:139530854-139530865
23	ELF1	chr7:139530739-139531311	GM12878	blood:	n/a	chr7:139530854-139530865
24	EP300	chr7:139529363-139529544	K562	blood:	n/a	chr7:139529422-139529432 chr7:139529369-139529383
25	EP300	chr7:139528892-139529160	GM12878	blood:	n/a	chr7:139528897-139528911
26	FOS	chr7:139528760-139529174	HUVEC	blood vessel:	n/a	chr7:139528964-139528975 chr7:139528964-139528976
27	FOSL2	chr7:139529208-139529666	A549	lung:	n/a	chr7:139529516-139529528 chr7:139529493-139529503
28	FOXA1	chr7:139536578-139536729	T-47D	breast:	n/a	n/a
29	FOXA2	chr7:139528704-139529560	A549	lung:	n/a	n/a
30	FOXM1	chr7:139529457-139529974	GM12878	blood:	n/a	n/a
31	GATA3	chr7:139530614-139530980	T-47D	breast:	n/a	chr7:139530856-139530866 chr7:139530868-139530875
32	IRF1	chr7:139530036-139530039	K562	blood:	n/a	n/a
33	IRF3	chr7:139528971-139529027	GM12878	blood:	n/a	n/a
34	JUND	chr7:139528970-139529065	K562	blood:	n/a	n/a
35	KAP1	chr7:139528973-139529901	HEK293	kidney:	n/a	n/a
36	KAP1	chr7:139529109-139529966	U2OS	brain:	n/a	n/a
37	MAFF	chr7:139528807-139529151	K562	blood:	n/a	n/a
38	MAFF	chr7:139538153-139538187	K562	blood:	n/a	chr7:139538154-139538172
39	MAFF	chr7:139538116-139538201	HepG2	liver:	n/a	chr7:139538154-139538172
40	MAFK	chr7:139538110-139538189	K562	blood:	n/a	chr7:139538156-139538171
41	MAFK	chr7:139538078-139538329	HepG2	liver:	n/a	chr7:139538156-139538171
42	MAFK	chr7:139528826-139529041	HepG2	liver:	n/a	chr7:139528959-139528974 chr7:139528964-139528973 chr7:139528958-139528972 chr7:139528964-139528974 chr7:139528828-139528843
43	MAFK	chr7:139528906-139529001	HepG2	liver:	n/a	chr7:139528959-139528974 chr7:139528964-139528973 chr7:139528958-139528972 chr7:139528964-139528974
44	MAFK	chr7:139538010-139538335	HepG2	liver:	n/a	chr7:139538156-139538171
45	MAFK	chr7:139528790-139529162	K562	blood:	n/a	chr7:139528959-139528974 chr7:139528964-139528973 chr7:139528958-139528972 chr7:139528964-139528974 chr7:139528828-139528843
46	MAFK	chr7:139528817-139529134	IMR90	lung:	n/a	chr7:139528959-139528974 chr7:139528964-139528973 chr7:139528958-139528972 chr7:139528964-139528974 chr7:139528828-139528843
47	MAX	chr7:139537653-139537823	K562	blood:	n/a	n/a
48	MAX	chr7:139528912-139529240	K562	blood:	n/a	n/a
49	MAX	chr7:139528914-139529329	K562	blood:	n/a	n/a
50	MAX	chr7:139528680-139529581	A549	lung:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:139528855-139528905	AG09319	gingival:	n/a
2	chr7:139528673-139528723	CMK	blood:	n/a
3	chr7:139528855-139528905	HEK293	kidney:	embryo
4	chr7:139529130-139529180	A549	lung:	n/a
5	chr7:139528673-139528723	HEEpiC	esophagus:	n/a
6	chr7:139528673-139528723	HPAEpiC	pulmonary alveolar:	n/a
7	chr7:139528855-139528905	HNPCEpiC	eye:	n/a
8	chr7:139528673-139528723	AG04450	lung:	fetal
9	chr7:139528673-139528723	Caco-2	colon:	n/a
10	chr7:139528855-139528905	HRPEpiC	eye:	n/a
11	chr7:139529130-139529180	HCPEpiC	choroid plexus:	n/a
12	chr7:139528673-139528723	AG09319	gingival:	n/a
13	chr7:139529130-139529180	SAEC	small airway:	n/a
14	chr7:139528855-139528905	NT2-D1	testis:	n/a
15	chr7:139529130-139529180	HCT-116	colon:	n/a
16	chr7:139528855-139528905	SKMC	muscle:	n/a
17	chr7:139528855-139528905	GM19239	blood:	n/a
18	chr7:139528673-139528723	PANC-1	pancreas:	n/a
19	chr7:139528673-139528723	GM12892	blood:	n/a
20	chr7:139528855-139528905	U87	brain:	n/a
21	chr7:139528855-139528905	H1-hESC	embryonic stem cell:	embryo
22	chr7:139529130-139529180	BE2_C	brain:	n/a
23	chr7:139529130-139529180	HRPEpiC	eye:	n/a
24	chr7:139528673-139528723	AG09309	skin:	n/a
25	chr7:139528855-139528905	SK-N-SH_RA	brain:	n/a
26	chr7:139528855-139528905	Caco-2	colon:	n/a
27	chr7:139528855-139528905	NH-A	brain:	n/a
28	chr7:139529130-139529180	GM12891	blood:	n/a
29	chr7:139528673-139528723	HL-60	blood:	n/a
30	chr7:139528855-139528905	K562	blood:	n/a
31	chr7:139528855-139528905	BE2_C	brain:	n/a
32	chr7:139529130-139529180	Jurkat	blood:	n/a
33	chr7:139528673-139528723	AoSMC	blood vessel:	n/a
34	chr7:139528673-139528723	HUVEC	blood vessel:	n/a
35	chr7:139528855-139528905	HCM	heart:	n/a
36	chr7:139529130-139529180	HRE	kidney:	n/a
37	chr7:139529130-139529180	HPAEpiC	pulmonary alveolar:	n/a
38	chr7:139528673-139528723	PFSK-1	brain:	n/a
39	chr7:139528673-139528723	A549	lung:	n/a
40	chr7:139528673-139528723	AG04449	skin:	fetal
41	chr7:139528855-139528905	SK-N-MC	brain:	n/a
42	chr7:139528855-139528905	ECC-1	luminal epithelium:	n/a
43	chr7:139528673-139528723	HepG2	liver:	n/a
44	chr7:139528673-139528723	NHBE	bronchial:	n/a
45	chr7:139528855-139528905	IMR90	lung:	fetal
46	chr7:139528855-139528905	NHDF-neo	bronchial:	n/a
47	chr7:139528855-139528905	HCT-116	colon:	n/a
48	chr7:139528673-139528723	PrEC	prostate:	n/a
49	chr7:139528855-139528905	RPTEC	kidney:	n/a
50	chr7:139528673-139528723	GM19239	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr7:139477083..139479483-chr7:139538319..139540657,2	K562	blood:
2	chr7:139538171..139540494-chr7:139550630..139553046,2	K562	blood:
3	chr7:139529269..139531920-chr7:139536482..139539397,2	MCF-7	breast:
4	chr7:139476813..139479584-chr7:139529025..139531896,2	MCF-7	breast:
5	chr7:139529269..139531920-chr7:139536482..139539397,2	MCF-7	breast:
6	chr7:139539840..139543405-chr7:139545009..139547964,3	K562	blood:
7	chr7:139532720..139535197-chr7:139540862..139542480,2	K562	blood:

Variant related genes	Relation type
TBXAS1	TF binding region
TBXAS1	CpG island
ENSG00000064393	chromatin interactions
ENSG00000059377	chromatin interactions

Extended variants
information (count: 439 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:439 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4590360	chr7:139528662-139528663	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs191869665	chr7:139528668-139528669	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs556866965	chr7:139528669-139528670	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs575251906	chr7:139528691-139528692	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs573773191	chr7:139528692-139528693	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs184200096	chr7:139528737-139528738	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs570400618	chr7:139528760-139528761	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs528331547	chr7:139528817-139528818	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs537992242	chr7:139528838-139528839	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs142557574	chr7:139528872-139528873	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs188949339	chr7:139528899-139528900	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs550709630	chr7:139528925-139528926	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs150958431	chr7:139528959-139528960	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs530155928	chr7:139528975-139528976	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs548303628	chr7:139529032-139529033	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs566610125	chr7:139529130-139529131	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs534162963	chr7:139529133-139529134	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs181789109	chr7:139529146-139529147	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs369114491	chr7:139529165-139529166	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs376526095	chr7:139529169-139529170	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs370626399	chr7:139529184-139529185	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs374330294	chr7:139529187-139529188	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs148207522	chr7:139529191-139529192	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs61733586	chr7:139529239-139529240	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs201600575	chr7:139529240-139529241	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs77579057	chr7:139529256-139529257	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs575146790	chr7:139529263-139529264	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs374729467	chr7:139529264-139529265	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs146180153	chr7:139529277-139529278	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs554747912	chr7:139529311-139529312	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs370214777	chr7:139529312-139529313	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs115736138	chr7:139529318-139529319	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs368031204	chr7:139529319-139529320	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs540432742	chr7:139529330-139529331	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs565052284	chr7:139529350-139529351	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs371911507	chr7:139529353-139529354	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs185744162	chr7:139529358-139529359	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs139547778	chr7:139529391-139529392	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs560812347	chr7:139529392-139529393	Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs541083759	chr7:139529460-139529461	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs562619563	chr7:139529485-139529486	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs530069042	chr7:139529505-139529506	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs548167954	chr7:139529506-139529507	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs566668966	chr7:139529510-139529511	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs527732471	chr7:139529547-139529548	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs552503042	chr7:139529566-139529567	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs190516658	chr7:139529568-139529569	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs538175147	chr7:139529585-139529586	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs572667947	chr7:139529652-139529653	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs372578465	chr7:139529659-139529660	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Wilms tumour	21544195	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Medulloblastoma	16783165	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Melanoma	19188590	CNVD
Glioblastoma multiforme	18628472	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant melanoma	17260012	CNVD
Coffin-Siris syndrome	21572526	CNVD
Papillary thyroid carcinoma	21436994	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Hodgkin''s lymphoma	18179710	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	16272173	CNVD
Myxofibrosarcoma	16751306	CNVD
Stuttering	21108403	CNVD
Breast cancer	17603634	CNVD
Urothelial carcinoma	18382360	CNVD
Myelodysplastic syndrome	17634407	CNVD
Bladder cancer	21909424	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
T-cell acute lymphoblastic leukemia	16673021	CNVD
Cancer	21183584	CNVD
Intracranial ependymoma	16609018	CNVD
Non-small cell lung cancer	21829676	CNVD
Developmental delay	19490664	CNVD
Pancreatitis	20877625	CNVD
Multiple myeloma	16461302	CNVD
Neuroblastoma	18923191	CNVD
Low-grade astrocytoma	19016743	CNVD
Medulloblastoma	16968546	CNVD
Pilocytic astrocytoma	18408760	CNVD
Idiopathic chronic pancreatitis	19584086	CNVD
Pediatric low-grade astrocytoma	19016743	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Gastric cancer	16891809	CNVD
Cancer	17440070	CNVD
Astrocytoma	18398503	CNVD
Melanoma	19671679	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Breast cancer	17133270	CNVD
Schizophrenia	17646849	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	21509527	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:272 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:139517200-139529200	Weak transcription	Right Atrium	heart
2	chr7:139525600-139529000	Weak transcription	Ovary	ovary
3	chr7:139526200-139528800	Weak transcription	Muscle Satellite Cultured Cells	--
4	chr7:139526200-139529000	Weak transcription	NH-A	brain
5	chr7:139526200-139530000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr7:139526400-139529000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr7:139526400-139535000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr7:139528000-139529000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr7:139528200-139528800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr7:139528200-139528800	Enhancers	Placenta	Placenta
11	chr7:139528200-139528800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
12	chr7:139528200-139529000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr7:139528200-139529000	Enhancers	Primary monocytes fromperipheralblood	blood
14	chr7:139528200-139529000	Enhancers	Primary B cells from peripheral blood	blood
15	chr7:139528200-139529000	Enhancers	Primary T cells fromperipheralblood	blood
16	chr7:139528200-139529000	Enhancers	Primary hematopoietic stem cells short term culture	blood
17	chr7:139528200-139529000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
18	chr7:139528200-139529000	Enhancers	Primary T helper cells PMA-I stimulated	--
19	chr7:139528200-139529000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
20	chr7:139528200-139529000	Enhancers	Primary T helper cells fromperipheralblood	blood
21	chr7:139528200-139529000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
22	chr7:139528200-139529000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
23	chr7:139528200-139529000	Enhancers	Fetal Thymus	thymus
24	chr7:139528200-139529000	Enhancers	Stomach Mucosa	stomach
25	chr7:139528200-139529000	Enhancers	Thymus	Thymus
26	chr7:139528200-139529200	Enhancers	Gastric	stomach
27	chr7:139528200-139529400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr7:139528200-139529400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr7:139528200-139531400	Enhancers	Fetal Kidney	kidney
30	chr7:139528200-139532000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
31	chr7:139528400-139528800	Enhancers	Adipose Nuclei	Adipose
32	chr7:139528400-139529000	Enhancers	Liver	Liver
33	chr7:139528400-139529000	Enhancers	Colonic Mucosa	Colon
34	chr7:139528400-139529000	Enhancers	Duodenum Mucosa	Duodenum
35	chr7:139528400-139529000	Enhancers	Lung	lung
36	chr7:139528400-139529000	Enhancers	Rectal Mucosa Donor 31	rectum
37	chr7:139528400-139529000	Enhancers	GM12878-XiMat	blood
38	chr7:139528400-139529000	Enhancers	HepG2	liver
39	chr7:139528400-139529400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
40	chr7:139528400-139529400	Enhancers	Fetal Intestine Small	intestine
41	chr7:139528400-139530200	Enhancers	Primary T killer memory cells from peripheral blood	blood
42	chr7:139528400-139530600	Flanking Active TSS	Primary B cells from cord blood	blood
43	chr7:139528400-139531000	Enhancers	Fetal Lung	lung
44	chr7:139528600-139528800	Flanking Active TSS	Primary hematopoietic stem cells	blood
45	chr7:139528600-139529000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr7:139528600-139529400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
47	chr7:139528600-139529400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
48	chr7:139528600-139529400	Enhancers	Spleen	Spleen
49	chr7:139528600-139529600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
50	chr7:139528600-139530000	Flanking Active TSS	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links